Johanna Goldfarb

Johanna Goldfarb

Auto-generated profile, based on publicly available information

Johanna Goldfarb

Pediatric Infectious Diseases, Cleveland Clinic Children's Hospital, Cleveland, Ohio

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Cleveland Clinic Journal of Medicine
Verified
Journal Article
Closed access
APAmy Porter
Amy Porter
JGJohanna Goldfarb
Johanna Goldfarb
Release date: June 1, 2019Expiration date: May 31, 2020Estimated time of completion: 1 hourClick here to start this CME/MOC activity.ABSTRACTAlthough a safe and effective vaccine has been available for over 6 decades, vaccine hesitancy in the United States and social and political unrest globally have led to undervaccination. As a result, in recent months, vaccine control of measles has been threatened with an alarming upswing in measles cases nationally and internationally. Here, we review the disease and its management in view of recent outbreaks.

17 June 2021 in Journal of Health Care Chaplaincy
Verified
Journal Article
Closed access
DCDena Crozier
Dena Crozier
AGAmy Greene
Amy Greene
MSMary Schleicher
Mary Schleicher
JGJohanna Goldfarb
Johanna Goldfarb
Though it has become increasingly clear that religion and spirituality are important aspects of whole patient care, little is known about how this topic is taught to medical students. This systemat...

1 July 2014 in Hospital Pediatrics
Verified
Journal Article
Closed access
PDF file
HTHelen Tewelde
Helen Tewelde
JYJeein Yoon
Jeein Yoon
WIWendy Van Ittersum
Wendy Van Ittersum
SWSarah Worley
Sarah Worley
TPTamar Preminger
Tamar Preminger
JGJohanna Goldfarb
Johanna Goldfarb
Objective: To describe and quantify the presentations of Kawasaki disease (KD) in a children’s hospital over 10 years to assess the Harada score in a US population. Methods: A retrospective chart review from 2001 to 2011 of children discharged from Cleveland Clinic with the diagnosis of KD. Demographic and clinical data were collected and Harada scores were derived to evaluate efficacy in predicting risk for coronary artery aneurysms (CAAs). Results: A total of 105 children met diagnostic criteria for KD, and 97 of 105 had long-term follow-up. Full criteria for KD were found in 67 of 105 (64%); 38 had incomplete presentations. CAA developed in 10 children, 5 during follow-up despite treatment with intravenous immunoglobulin (IVIG.) Children with incomplete presentations had a higher risk of developing CAA (20% vs 5%, P = .03) and a delayed diagnosis (median days from fever to diagnosis 8.0 vs 5.0 days, P < .001). Of children who developed CAA, 9 of 10 had a positive Harada score (sensitivity of 90%). All children who developed CAA after IVIG were in the high-risk group, but 1 child with an incomplete presentation who had a CAA at presentation was missed by the score. Overall, the negative predictive value was 98%. Conclusions: As in Japanese studies, a positive Harada score in a US population could be used to identify a high-risk population for CAA development. All children who developed CAA after treatment with IVIG would have been assigned to a high-risk category. Though not specific enough to select initial therapy, the score might be useful in identifying high-risk children for evaluation of new therapies and more frequent follow-up.

21 June 2006 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Closed access
PDF file
SYStephanie Yee-Guardino
Stephanie Yee-Guardino
LDLara Danziger-Isakov
Lara Danziger-Isakov
MKMark Knouse
Mark Knouse
WBWilliam Bingaman
William Bingaman
CSCamille Sabella
Camille Sabella
JGJohanna Goldfarb
Johanna Goldfarb
Pseudomonas stutzeriis a rare cause of nosocomial infection. We report a pediatric case of nosocomially acquiredP. stutzeribrain abscess after subdural grid implantation before surgery for refractory epilepsy and review the literature.

27 January 2016 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
JGJohanna Goldfarb
Johanna Goldfarb
NBNirica Borges
Nirica Borges
LGLaura K. Gowans
Laura K. Gowans
DKDebra Kohn
Debra Kohn
SWSarah Worley
Sarah Worley
PPPhilip E. Pellett
Philip E. Pellett

1 February 2002 in Cleveland Clinic Journal of Medicine
Verified
Journal Article
Closed access
JGJ. Goldfarb
J. Goldfarb